Liberator Medical Holdings, Inc. (OTCBB:LBMH) Retreats Near $2

After a hiccup on Friday that sliced 11 cents off the share price of Liberator Medical Holdings, Inc. (OTCBB:LBMH), the ticker took a bigger plunge yesterday and dropped a little over 7% to come to a close of $2.04 per share.

The stock moved twice its average volume, at over 400 thousand shares changing hands, with visible volume spikes in the early session. The Friday recovery immediately after the close seems to have been ignored and LBMH opened even further down from its dip to $2.10 late last week. The morning heavy volume action momentarily pressed the stock below the two-dollar mark but the price recovered slightly by the closing bell.

Once again, the drop was triggered by no immediately obvious reasons and could easily have been people cashing out their positions at a nicely increased price level. There have been no new PR announcements from Liberator and their most recent filing concerns their annual shareholder meeting. The meeting’s primary concerns will be the election of three directors to the board and retaining LBMH‘s current accounting firm for another year.

Without any grim news on the horizon and with the most current financial report still boasting strong figures, the slip does resemble a cash-out. Whether the quick drop of over 30 cents in just two sessions will be enough to scare even more traders out of the stock remains to be seen but considering the recent volatility of the stock, caution is advised.

Other big penny movers from yesterday’s session include Nutranomics, Inc., f/k/a Buka Ventures, Inc. (OTCBB:NNRX) who, after a few days of steady pumping, crashed horribly and wiped out all gains made during the climb, and then some. Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) also dropped by a quarter, stopping at $0.59 per share after a two-day climb.